| Evaluation of physiologically based pharmacokinetic models for use in risk assessment WA Chiu, HA Barton, RS DeWoskin, P Schlosser, CM Thompson, ... Journal of applied toxicology 27 (3), 218-237, 2007 | 165 | 2007 |
| Assessment of the mode of action for hexavalent chromium-induced lung cancer following inhalation exposures DM Proctor, M Suh, SL Campleman, CM Thompson Toxicology 325, 160-179, 2014 | 152 | 2014 |
| Derivation of point of departure (PoD) estimates in genetic toxicology studies and their potential applications in risk assessment GE Johnson, LG Soeteman‐Hernández, BB Gollapudi, OG Bodger, ... Environmental and molecular mutagenesis, 2014 | 140 | 2014 |
| A chronic oral reference dose for hexavalent chromium‐induced intestinal cancer CM Thompson, CR Kirman, DM Proctor, LC Haws, M Suh, SM Hays, ... Journal of Applied Toxicology 34 (5), 525-536, 2014 | 135 | 2014 |
| Activation of G-proteins by morphine and codeine congeners: insights to the relevance of O-and N-demethylated metabolites at μ-and δ-opioid receptors CM Thompson, H Wojno, E Greiner, EL May, KC Rice, DE Selley Journal of Pharmacology and Experimental Therapeutics 308 (2), 547-554, 2004 | 114 | 2004 |
| Database for physiologically based pharmacokinetic (PBPK) modeling: physiological data for healthy and health-impaired elderly CM Thompson, DO Johns, B Sonawane, HA Barton, D Hattis, R Tardif, ... Journal of Toxicology and Environmental Health, Part B 12 (1), 1-24, 2009 | 112 | 2009 |
| Assessment of the mode of action underlying development of rodent small intestinal tumors following oral exposure to hexavalent chromium and relevance to humans CM Thompson, DM Proctor, M Suh, LC Haws, CR Kirman, MA Harris Critical reviews in toxicology 43 (3), 244-274, 2013 | 99 | 2013 |
| Investigation of the mode of action underlying the tumorigenic response induced in B6C3F1 mice exposed orally to hexavalent chromium CM Thompson, DM Proctor, LC Haws, CD Hébert, SD Grimes, ... Toxicological Sciences 123 (1), 58-70, 2011 | 96 | 2011 |
| Protein Expression, Characterization, and Regulation ofCYP4F4andCYP4F5Cloned from Rat Brain H Kawashima, E Kusunose, CM Thompson, HW Strobel Archives of biochemistry and biophysics 347 (1), 148-154, 1997 | 93 | 1997 |
| Application of the US EPA mode of action Framework for purposes of guiding future research: a case study involving the oral carcinogenicity of hexavalent chromium CM Thompson, LC Haws, MA Harris, NM Gatto, DM Proctor Toxicological Sciences 119 (1), 20-40, 2011 | 91 | 2011 |
| Cytochromes P450 in brain: function and significance HW Strobel, CM Thompson, L Antonovic Current drug metabolism 2 (2), 199-214, 2001 | 88 | 2001 |
| Assessment of Cr (VI)-Induced Cytotoxicity and Genotoxicity Using High Content Analysis CM Thompson, Y Fedorov, DD Brown, M Suh, DM Proctor, L Kuriakose, ... PLoS ONE 7 (8), e42720, 2012 | 82 | 2012 |
| The vesicle transport protein Vps33p is an ATP-binding protein that localizes to the cytosol in an energy-dependent manner B Gerhardt, TJ Kordas, CM Thompson, P Patel, T Vida Journal of Biological Chemistry 273 (25), 15818-15829, 1998 | 80 | 1998 |
| Recombinant cytochrome P450 2D18 metabolism of dopamine and arachidonic acid CM Thompson, JH Capdevila, HW Strobel Journal of Pharmacology and Experimental Therapeutics 294 (3), 1120-1130, 2000 | 79 | 2000 |
| Approaches for applications of physiologically based pharmacokinetic models in risk assessment CM Thompson, B Sonawane, HA Barton, RS DeWoskin, JC Lipscomb, ... Journal of Toxicology and Environmental Health, Part B 11 (7), 519-547, 2008 | 66 | 2008 |
| Comparison of the Effects of Hexavalent Chromium in the Alimentary Canal of F344 Rats and B6C3F1 Mice Following Exposure in Drinking Water: Implications for Carcinogenic Modes … CM Thompson, DM Proctor, M Suh, LC Haws, CD Hébert, JF Mann, ... Toxicological Sciences 125 (1), 79-90, 2012 | 64 | 2012 |
| Utilizing toxicogenomic data to understand chemical mechanism of action in risk assessment VS Wilson, N Keshava, S Hester, D Segal, W Chiu, CM Thompson, ... Toxicology and applied pharmacology 271 (3), 299-308, 2013 | 63 | 2013 |
| Renal clearance parameters for PBPK model analysis of early lifestage differences in the disposition of environmental toxicants RS DeWoskin, CM Thompson Regulatory Toxicology and Pharmacology 51 (1), 66-86, 2008 | 61 | 2008 |
| Genome-wide gene expression effects in B6C3F1 mouse intestinal epithelia following 7 and 90days of exposure to hexavalent chromium in drinking water AK Kopec, S Kim, AL Forgacs, TR Zacharewski, DM Proctor, MA Harris, ... Toxicology and applied pharmacology 259 (1), 13-26, 2012 | 60 | 2012 |
| Physiologically based pharmacokinetic model for rats and mice orally exposed to chromium CR Kirman, SM Hays, LL Aylward, M Suh, MA Harris, CM Thompson, ... Chemico-biological interactions 200 (1), 45-64, 2012 | 58 | 2012 |
